<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00789529</url>
  </required_header>
  <id_info>
    <org_study_id>CS-101</org_study_id>
    <nct_id>NCT00789529</nct_id>
  </id_info>
  <brief_title>Objective Testing of Tear Film Stability</brief_title>
  <official_title>Objective Testing of Tear Film Stability</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Manhattan Vision Associates</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Manhattan Vision Associates</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the in-vivo wettability of soft contact lenses when
      cared with two different multi-purpose solutions over a two week wearing period.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">November 2008</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Objective, In-vivo Soft Contact Lens Wettability Index</measure>
    <time_frame>2 weeks</time_frame>
    <description>The wettability index is derived from the slope of a metric developed to measure the regularity of the Shack-Hartmann wavefront sensor image. The more wettable a lens is the more stable the metric and the slope of the metric (the wettability index) is closer to zero. The more negative values indicate a less wettable the lens.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subject Questionnaire Response</measure>
    <time_frame>2 weeks</time_frame>
    <description>Subject questionnaire response: Overall comfort at 2 weeks in a 0-50 point scale.
0=Very poor 50 = Excellent</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Contact Lens Solutions</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Opti-Free® RepleniSH® MPDS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Renu MultiPlus®</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Opti-Free® RepleniSH® MPDS</intervention_name>
    <description>soft contact lens disinfecting solution</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ReNu MultiPlus®</intervention_name>
    <description>soft contact lens disinfecting solution</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The subject must be at least 18 years of age and no more than 80 years of age.

          2. The subject must have a best corrected visual acuity of 20/30 or better for each eye.

          3. The subject must habitually wear contact lenses.

          4. The subject must have had an eye exam within the last 12 months. The exam data must be
             available to the investigators prior to the first visit.

          5. The subject must have normal eyes, no use of ocular medications, no ocular infection
             of any type, and no ocular inflammation.

          6. The subject must read understand and sign the Statement of Informed Consent.

          7. The subject must appear able and willing to adhere to the instructions set forth in
             this clinical protocol.

        Exclusion Criteria:

          1. Ocular or systemic allergies or disease that might interfere with contact lens wear.

          2. Systemic disease, autoimmune disease or use of medication which might interfere with
             contact lens wear.

          3. Clinically significant (FDA Scale grade 3 or 4) corneal edema, corneal
             vascularization, corneal staining or any other abnormalities of the cornea which would
             contraindicate contact lens wear.

          4. Clinically significant (FDA Scale grade 3 or 4) tarsal abnormalities or bulbar
             injection which might interfere with contact lens wear.

          5. Any ocular infection.

          6. Pregnancy or lactation.

          7. Diabetes

          8. Infectious diseases (e.g. hepatitis, tuberculosis)

          9. Contagious immunosuppressive diseases (e.g. HIV)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>George Zikos, OS, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>MVA/IVR</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>MVA/IVR</name>
      <address>
        <city>New York City</city>
        <state>New York</state>
        <zip>10022</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 11, 2008</study_first_submitted>
  <study_first_submitted_qc>November 12, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2008</study_first_posted>
  <results_first_submitted>July 25, 2011</results_first_submitted>
  <results_first_submitted_qc>April 22, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 31, 2013</results_first_posted>
  <last_update_submitted>April 22, 2013</last_update_submitted>
  <last_update_submitted_qc>April 22, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 31, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Contact lenses, wettability, Contact Lens Disinfectant Solutions, pre-lens tear film</keyword>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment of patients was conducted by approaching the patients seen in the practice.</recruitment_details>
      <pre_assignment_details>32 subjects were recruited and enrolled in the study. No subjects had to be excluded.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>1 - ReNu MultiPlus First, Opti-Free RepleniSH Second</title>
          <description>Used ReNu MultiPlus multi-purpose solution for the care of new contact lenses in the first intervention period, and used Opti-Free RepleniSH multi-purpose disinfecting solution for the care of new contact lenses in the second intervention period</description>
        </group>
        <group group_id="P2">
          <title>2 - Opti-Free RepleniSH First, ReNu MultiPlus Second</title>
          <description>Used Opti-Free RepleniSH multi-purpose disinfecting solution for the care of new contact lenses in the first intervention period, and used ReNu MultiPlus multi-purpose solution for the care of new contact lenses in the second intervention period</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other Reason</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>1 - ReNu MultiPlus First</title>
          <description>Used ReNu MultiPlus first, Opti-Free RepleniSH Second</description>
        </group>
        <group group_id="B2">
          <title>2 - Opti-Free RepleniSH First</title>
          <description>Opti-Free RepleniSH first, ReNu MultiPlus Second</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="16"/>
            <count group_id="B2" value="16"/>
            <count group_id="B3" value="32"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.3" spread="3.8"/>
                    <measurement group_id="B2" value="27.4" spread="5.1"/>
                    <measurement group_id="B3" value="27.3" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Objective, In-vivo Soft Contact Lens Wettability Index</title>
        <description>The wettability index is derived from the slope of a metric developed to measure the regularity of the Shack–Hartmann wavefront sensor image. The more wettable a lens is the more stable the metric and the slope of the metric (the wettability index) is closer to zero. The more negative values indicate a less wettable the lens.</description>
        <time_frame>2 weeks</time_frame>
        <population>Per protocol. All participants that completed both arms were analysed.</population>
        <group_list>
          <group group_id="O1">
            <title>Opti-Free® RepleniSH® MPDS</title>
            <description>Used Opti-Free® RepleniSH® MPDS</description>
          </group>
          <group group_id="O2">
            <title>Renu MultiPlus®</title>
            <description>Used Renu MultiPlus®</description>
          </group>
        </group_list>
        <measure>
          <title>Objective, In-vivo Soft Contact Lens Wettability Index</title>
          <description>The wettability index is derived from the slope of a metric developed to measure the regularity of the Shack–Hartmann wavefront sensor image. The more wettable a lens is the more stable the metric and the slope of the metric (the wettability index) is closer to zero. The more negative values indicate a less wettable the lens.</description>
          <population>Per protocol. All participants that completed both arms were analysed.</population>
          <units>wettability index</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.82" spread="2.88"/>
                    <measurement group_id="O2" value="-1.98" spread="2.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject Questionnaire Response</title>
        <description>Subject questionnaire response: Overall comfort at 2 weeks in a 0-50 point scale.
0=Very poor 50 = Excellent</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Opti-Free® RepleniSH® MPDS</title>
            <description>Used Opti-Free® RepleniSH® MPDS</description>
          </group>
          <group group_id="O2">
            <title>Renu MultiPlus®</title>
            <description>Used Renu MultiPlus®</description>
          </group>
        </group_list>
        <measure>
          <title>Subject Questionnaire Response</title>
          <description>Subject questionnaire response: Overall comfort at 2 weeks in a 0-50 point scale.
0=Very poor 50 = Excellent</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.7" spread="7.3"/>
                    <measurement group_id="O2" value="43.1" spread="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Length of study was 24 to 32 days.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>1 - ReNu MultiPlus First</title>
          <description>Used ReNu MultiPlus first, Opti-Free RepleniSH Second</description>
        </group>
        <group group_id="E2">
          <title>2 - Opti-Free RepleniSH First</title>
          <description>Opti-Free RepleniSH first, ReNu MultiPlus Second</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. George Zikos</name_or_title>
      <organization>Manhattan Vision Associates / Institute for Vision Research</organization>
      <phone>2126884277</phone>
      <email>gzikos@mvaivr.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

